China Biologic Products

INVESTOR DEADLINE: Investors in Enochian Biosciences Inc. with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – ENOB

Retrieved on: 
Saturday, August 6, 2022 - 9:15am

The Enochian Biosciences class action lawsuit captioned Chow v. Enochian Biosciences Inc., No.

Key Points: 
  • The Enochian Biosciences class action lawsuit captioned Chow v. Enochian Biosciences Inc., No.
  • Enochian Biosciences and its top management have credited Serhat Gumrukcu (Gumrukcu), Enochian Biosciences co-founder, as the inventor of the technology and science behind Enochian Biosciences product pipeline.
  • A lead plaintiff acts on behalf of all other class members in directing the Enochian Biosciences class action lawsuit.
  • The lead plaintiff can select a law firm of its choice to litigate the Enochian Biosciences class action lawsuit.

Global Biopharmaceutical Excipients Market Report 2022-2027: Pipeline and Product Approvals, a Major driver for Biopharmaceutical Excipients Market - ResearchAndMarkets.com

Retrieved on: 
Friday, August 5, 2022 - 3:12pm

The "Biopharmaceutical Excipients Market - Global Outlook and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Biopharmaceutical Excipients Market - Global Outlook and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
  • The global biopharmaceutical excipients market is expected to grow at a CAGR of 7.56% during 2022-2027.
  • The market for solubility-enhancing excipients and related technologies is proliferating to tackle the problem.
  • Biologics- Pipeline and Product Approvals, a Major driver for Biopharmaceutical Excipients Market
    With a growing number of infectious diseases and cancers, there is a high demand for various biologic drugs.

INVESTOR NOTICE: Enochian Biosciences Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - ENOB

Retrieved on: 
Tuesday, August 2, 2022 - 3:10pm

The Enochian Biosciences class action lawsuit captioned Chow v. Enochian Biosciences Inc., No.

Key Points: 
  • The Enochian Biosciences class action lawsuit captioned Chow v. Enochian Biosciences Inc., No.
  • Enochian Biosciences and its top management have credited Serhat Gumrukcu (Gumrukcu), Enochian Biosciences co-founder, as the inventor of the technology and science behind Enochian Biosciences product pipeline.
  • A lead plaintiff acts on behalf of all other class members in directing the Enochian Biosciences class action lawsuit.
  • The lead plaintiff can select a law firm of its choice to litigate the Enochian Biosciences class action lawsuit.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Enochian Biosciences Inc. of Class Action Lawsuit and Upcoming Deadline – ENOB

Retrieved on: 
Monday, August 1, 2022 - 6:02pm

NEW YORK, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. (Enochian or the Company) (NASDAQ: ENOB) and certain of its officers and directors.

Key Points: 
  • NEW YORK, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. (Enochian or the Company) (NASDAQ: ENOB) and certain of its officers and directors.
  • To discuss this action, contact Robert S. Willoughby at newaction@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

Enochian Biosciences Inc. Shareholder Update: Robbins LLP Reminds Investors of Class Action Against Enochian Biosciences Inc. (ENOB)

Retrieved on: 
Monday, August 1, 2022 - 6:02pm

The Class: Shareholder rights law firm Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons or entities that purchased or otherwise acquired Enochian Biosciences Inc. (NASDAQ: ENOB) securities between September 24, 2020 and May 31, 2022, for violations of the Securities Exchange Act of 1934.

Key Points: 
  • The Class: Shareholder rights law firm Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons or entities that purchased or otherwise acquired Enochian Biosciences Inc. (NASDAQ: ENOB) securities between September 24, 2020 and May 31, 2022, for violations of the Securities Exchange Act of 1934.
  • If you would like more information about Enochian Biosciences Inc.'s misconduct, click here .
  • On May 25, 2022, the U.S. Department of Justice announced that Gumrukcu had been arrested and charged in a murder-for-hire conspiracy.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Enochian and Weber and Encourages Investors to Contact the Firm

Retrieved on: 
Monday, August 1, 2022 - 2:00am

On May 25, 2022, the U.S. Department of Justice announced that Gumrukcu had been arrested and charged in a murder-for-hire conspiracy.

Key Points: 
  • On May 25, 2022, the U.S. Department of Justice announced that Gumrukcu had been arrested and charged in a murder-for-hire conspiracy.
  • On this news, Enochians stock price fell $2.17 per share, or 36.97%, to close at $3.70 per share on May 25, 2022.
  • Additionally, Weber announced that Chris Scherzinger is departing from his roles as Chief Executive Officer and director of the Company.
  • For more information on the Weber class action go to: https://bespc.com/cases/WEBR
    About Bragar Eagel & Squire, P.C.

FDA Provides Update on Agency Response to Monkeypox Outbreak

Retrieved on: 
Friday, July 29, 2022 - 9:03pm

The agency has also established a dedicated website to provide important information about the FDA's ongoing regulatory activities related to monkeypox along with frequently asked questions.

Key Points: 
  • The agency has also established a dedicated website to provide important information about the FDA's ongoing regulatory activities related to monkeypox along with frequently asked questions.
  • "The FDA has been closely tracking reports of monkeypox transmissions in the United States with our federal public health partners and coordinating preparedness efforts accordingly," said FDA Commissioner Robert M. Califf, M.D.
  • The FDA will continue to work with the diagnostic community to augment access to accurate testing to support the response.
  • The FDA continues to work with the CDC to streamline their Expanded Access Program for monkeypox to facilitate access.

Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Enochian Biosciences Inc. (ENOB)

Retrieved on: 
Thursday, July 28, 2022 - 3:31pm

The Class: Shareholder rights law firm Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons or entities that purchased or otherwise acquired Enochian Biosciences Inc. (NASDAQ: ENOB) securities between September 24, 2020 and May 31, 2022, for violations of the Securities Exchange Act of 1934.

Key Points: 
  • The Class: Shareholder rights law firm Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons or entities that purchased or otherwise acquired Enochian Biosciences Inc. (NASDAQ: ENOB) securities between September 24, 2020 and May 31, 2022, for violations of the Securities Exchange Act of 1934.
  • If you would like more information about Enochian Biosciences Inc.'s misconduct, click here .
  • On May 25, 2022, the U.S. Department of Justice announced that Gumrukcu had been arrested and charged in a murder-for-hire conspiracy.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Angel Yeast Showcases Latest Innovation in Fermentation Nutrients at Bio China 2022

Retrieved on: 
Thursday, July 28, 2022 - 1:00pm

JINAN, China, July 28, 2022 /PRNewswire/ -- Angel Yeast (SH600298), a globally listed yeast and yeast extract manufacturer, exhibited its latest products and solutions of fermentation nutrients at Bio China 2022, an expo on fermentation and biotechnology held in Jinan, Shandong province.

Key Points: 
  • JINAN, China, July 28, 2022 /PRNewswire/ -- Angel Yeast (SH600298), a globally listed yeast and yeast extract manufacturer, exhibited its latest products and solutions of fermentation nutrients at Bio China 2022, an expo on fermentation and biotechnology held in Jinan, Shandong province.
  • Angel Yeast has a longstanding commitment to creating a healthy life with innovation.
  • Plant nitrogen source products by Angel Yeast can be used in conjunction with yeast-sourced fermentation nutrients to improve downstream performance and efficiency.
  • Founded in 1986, Angel Yeast Co., Ltd specializes in the production of yeast and yeast derivatives.

Angel Yeast Showcases Latest Innovation in Fermentation Nutrients at Bio China 2022

Retrieved on: 
Thursday, July 28, 2022 - 1:00pm

JINAN, China, July 28, 2022 /PRNewswire/ -- Angel Yeast (SH600298), a globally listed yeast and yeast extract manufacturer, exhibited its latest products and solutions of fermentation nutrients at Bio China 2022, an expo on fermentation and biotechnology held in Jinan, Shandong province.

Key Points: 
  • JINAN, China, July 28, 2022 /PRNewswire/ -- Angel Yeast (SH600298), a globally listed yeast and yeast extract manufacturer, exhibited its latest products and solutions of fermentation nutrients at Bio China 2022, an expo on fermentation and biotechnology held in Jinan, Shandong province.
  • Angel Yeast has a longstanding commitment to creating a healthy life with innovation.
  • Plant nitrogen source products by Angel Yeast can be used in conjunction with yeast-sourced fermentation nutrients to improve downstream performance and efficiency.
  • Founded in 1986, Angel Yeast Co., Ltd specializes in the production of yeast and yeast derivatives.